Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




DNA Analysis Systems Reduce DNA Input and Increase Sample Throughput

By Labmedica staff writers
Posted on 16 Jan 2008
Two new products for DNA analysis double sample throughput and reduce DNA input requirements by as much as 70%. More...
They offer enhanced signal discrimination and a new single nucleotide polymorphism (SNP) algorithm.

Launched by Illumina's (San Diego, CA, USA) microarray business, the two new products are on the Human1M-Duo beadchip and contain markers for more than one million diverse genetic variants, all of which can be used for both whole-genome genotyping and copy number variation (CNV) analysis.

In addition to Human1M single-sample BeadChip, Illumina's new Human1M-Duo features can identify disease-associated SNPs and intelligently select high-density SNPs in coding regions of the genome. The Human1M-Duo also provides the highest available power to detect SNPs associated with diseases and the least number of large gaps for the identification of CNVs.
The Infinium HD Human1M-Duo (two samples/chip) and the Human610-Quad (four samples/chip), feature up to 2.3 million single nucleotide polymorphisms (SNPs) per beadchip. First customer shipments of the Human610-Quad and Human1M-Duo beadchips are expected in the first and second quarters of 2008, respectively.

The four-sample format of the Human610-Quad beadchip provides customers with a significant increase in sample throughput and reduced handling in the lab. Built upon the content of Illumina's broadly adopted HumanHap550 beadchip, the Human610-Quad beadchip has 550,000 SNPs plus an additional 60,000 genetic markers per sample. Both the Infinium HD Human1M-Duo and Human610-Quad beadchips include high-value, CNV content developed in conjunction with deCODE genetics, only found on Illumina arrays.

"The Human1M-Duo and Human610-Quad beadchips provide our customers with significant advances, including increased sample throughput, lower input sample volume, and improvements to the Infinium assay that enhance overall system performance. Concurrent with the development of these new array products, Illumina has implemented new decoding instruments into its operations that will effectively double Illumina's array manufacturing capacity over the next several quarters,” said John Stuelpnagel, senior vice president, COO, and general manager of Illumina's Microarray Business.

Illumina's genotyping solutions offer a flexible beadchip design and high-density architecture. Infinium HD products provide a powerful complement to Illumina's genotyping offering, which includes Infinium II, iSelect Infinium, GoldenGate, and VeraCode genotyping products.


Related Links:
Illumina

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.